Lupin shares in focus as USFDA inspection at Somerset facility concludes with no observations
- Posted on February 3, 2025
- By Business News Today
- 2 Views
Lupin shares in focus as USFDA inspection at Somerset facility concludes with no observations
Earlier in January, the company received the Establishment Inspection Report (EIR) from USFDA for its Pithampur Unit-1 manufacturing facility which manufactures both APIs and finished products.
